NIH | National Cancer Institute | NCI Wiki  
Long NameStaging, Soft Tissue Sarcoma NCI Standard Template
DefinitionThe collection of CDEs used in the soft tissue sarcoma staging module.
ContextcaBIG
Protocol Long NameNCI Standard Template Forms
WorkflowRELEASED
TypeCRF
Public ID3443747
Version1.0
Module Long NameModule InstructionsQuestionCDECDE Public IDCDE VersionQuestion InstructionsValue Domain Data TypeValue Domain Unit of MeasureDisplay FormatValid ValueForm Value Meaning TextForm Value Meaning Desc.
Mandatory Soft Tissue Sarcoma QuestionsThese items must be included when this data is collected for reporting.
Date Current Staging Assessment CompletedCurrent Stage Complete Assessment Date627393.0DATEMM/DD/YYYY
Conditional Soft Tissue Sarcoma QuestionsThere are business rules to indicate situations under which this element should be used on a case report form.
Clinical T StageSoft Tissue Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 Clinical Tumor T Stage34317081.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
TXSoft Tissue Sarcoma pTX TNM Finding v7Soft tissue sarcoma in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)
T0Soft Tissue Sarcoma pT0 TNM Finding v7Soft tissue sarcoma with no evidence of primary tumor. (from AJCC 7th Ed.)
T1Soft Tissue Sarcoma pT1 TNM Finding v7Soft tissue sarcoma with tumor measuring 5 cm or less in greatest dimension. (from AJCC 7th Ed.)
T1aSoft Tissue Sarcoma pT1a TNM Finding v7Soft tissue sarcoma with superficial tumor measuring 5 cm or less in greatest dimension. (from AJCC 7th Ed.)
T1bSoft Tissue Sarcoma pT1b TNM Finding v7Soft tissue sarcoma with deep tumor measuring 5 cm or less in greatest dimension. (from AJCC 7th Ed.)
T2Soft Tissue Sarcoma pT2 TNM Finding v7Soft tissue sarcoma with tumor measuring more than 5 cm in greatest dimension. (from AJCC 7th Ed.)
T2aSoft Tissue Sarcoma pT2a TNM Finding v7Soft tissue sarcoma with superficial tumor measuring more than 5 cm in greatest dimension. (from AJCC 7th Ed.)
T2bSoft Tissue Sarcoma pT2b TNM Finding v7Soft tissue sarcoma with deep tumor measuring more than 5 cm in greatest dimension. (from AJCC 7th Ed.)
Clinical N StageSoft Tissue Sarcoma Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Regional Lymph Node N Stage34317091.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
NXSoft Tissue Sarcoma pNX TNM Finding v7Soft tissue sarcoma in which regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)
N0Soft Tissue Sarcoma pN0 TNM Finding v7Soft tissue sarcoma without regional lymph node metastasis. (from AJCC 7th Ed.)
N1Soft Tissue Sarcoma pN1 TNM Finding v7Soft tissue sarcoma with regional lymph node metastasis. Note: Presence of positive nodes (N1) in M0 tumors is considered Stage III. (from AJCC 7th Ed.)
Clinical M StageSoft Tissue Sarcoma Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Distant Metastasis M Stage34317101.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
M0Soft Tissue Sarcoma cM0 TNM Finding v7Soft tissue sarcoma without evidence of distant metastasis. (from AJCC 7th Ed.)
M1Soft Tissue Sarcoma cM1 TNM Finding v7Soft tissue sarcoma with distant metastasis. (from AJCC 7th Ed.)
Pathologic T StageSoft Tissue Sarcoma Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Tumor T Stage34317111.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
TXSoft Tissue Sarcoma pTX TNM Finding v7Soft tissue sarcoma in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)
T0Soft Tissue Sarcoma pT0 TNM Finding v7Soft tissue sarcoma with no evidence of primary tumor. (from AJCC 7th Ed.)
T1Soft Tissue Sarcoma pT1 TNM Finding v7Soft tissue sarcoma with tumor measuring 5 cm or less in greatest dimension. (from AJCC 7th Ed.)
T1aSoft Tissue Sarcoma pT1a TNM Finding v7Soft tissue sarcoma with superficial tumor measuring 5 cm or less in greatest dimension. (from AJCC 7th Ed.)
T1bSoft Tissue Sarcoma pT1b TNM Finding v7Soft tissue sarcoma with deep tumor measuring 5 cm or less in greatest dimension. (from AJCC 7th Ed.)
T2Soft Tissue Sarcoma pT2 TNM Finding v7Soft tissue sarcoma with tumor measuring more than 5 cm in greatest dimension. (from AJCC 7th Ed.)
T2aSoft Tissue Sarcoma pT2a TNM Finding v7Soft tissue sarcoma with superficial tumor measuring more than 5 cm in greatest dimension. (from AJCC 7th Ed.)
T2bSoft Tissue Sarcoma pT2b TNM Finding v7Soft tissue sarcoma with deep tumor measuring more than 5 cm in greatest dimension. (from AJCC 7th Ed.)
Pathologic N StageSoft Tissue Sarcoma Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Regional Lymph Node N Stage34317121.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
NXSoft Tissue Sarcoma pNX TNM Finding v7Soft tissue sarcoma in which regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)
N0Soft Tissue Sarcoma pN0 TNM Finding v7Soft tissue sarcoma without regional lymph node metastasis. (from AJCC 7th Ed.)
N1Soft Tissue Sarcoma pN1 TNM Finding v7Soft tissue sarcoma with regional lymph node metastasis. Note: Presence of positive nodes (N1) in M0 tumors is considered Stage III. (from AJCC 7th Ed.)
Pathologic M StageSoft Tissue Sarcoma Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Distant Metastasis M Stage34317131.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
M1Soft Tissue Sarcoma pM1 TNM Finding v7Soft tissue sarcoma with distant metastasis. (from AJCC 7th Ed.)
Disease StageSoft Tissue Sarcoma Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage34317141.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
IAStage IA Soft Tissue SarcomaStage IA includes: (T1a, N0, M0, G1, GX); (T1b, N0, M0, G1, GX). T1a: Superficial tumor 5 cm or less in greatest dimension. T1b: Deep tumor 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Grade 1. GX: Grade cannot be assessed. (AJCC 7th ed.)
IBStage IB Soft Tissue SarcomaStage IB includes: (T2a, N0, M0, G1, GX); (T2b, N0, M0, G1, GX). T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Grade 1. GX: Grade cannot be assessed. (AJCC 7th ed.)
IIAStage IIA Soft Tissue SarcomaStage IIA includes: (T1a, N0, M0, G2, G3); (T1b, N0, M0, G2, G3). T1a: Superficial tumor 5 cm or less in greatest dimension. T1b: Deep tumor 5 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Grade 2. G3: Grade 3. (AJCC 7th ed.)
IIBStage IIB Soft Tissue SarcomaStage IIB includes: (T2a, N0, M0, G2); (T2b, N0, M0, G2). T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G2: Grade 2. (AJCC 7th ed.)
IIIStage III Soft Tissue SarcomaStage III includes: (T2a, T2b, N0, M0, G3); (Any T, N1, M0, Any G). T2a: Superficial tumor more than 5 cm in greatest dimension. T2b: Deep tumor more than 5 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. G3: Grade 3. There is no T2a for the pathologic group. (AJCC 7th ed.)
IVStage IV Soft Tissue SarcomaStage IV includes: Any T, Any N, M1, Any G. M1: Distant metastasis. (AJCC 7th ed.)
Stage unknownStage UnknownA finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.
Optional Soft Tissue Sarcoma QuestionsThere is no requirement for inclusion of these elements on the case report form. If the design and scientific questions posed in the study dictate the need to collect this type of data, these elements should be included.
Staging Time PointDisease Staging Timepoint Name28473521.0CHARACTER
Current DiagnosisCurrent DiagnosisOccurring in or belonging to the present time.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.
Initial DiagnosisFirst DiagnosisPreceding all others in time or space or degree.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.
RestagingRestagingRepeat of staging assessment
Study EnrollmentClinical Study EnrollmentResearch conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research. : Enrollment; to insert, register, or enter in a list, catalog, or roll. (Merriam-Webster Online)